Zhening Q. Pu

299 Qingyang Road
Wuxi, 214023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

IGSF3 drives acquired temozolomide resistance in glioblastoma through ASNS-dependent asparagine biosynthesis.

IGSF3 drives acquired temozolomide resistance in glioblastoma through ASNS-dependent asparagine biosynthesis.

Journal: The Journal of biological chemistry

Published: March 31, 2026

Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.

Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 12, 2025

COL6A2: A Key Survival-Related Gene and Restricting Antitumor Immunity in Glioblastoma.

COL6A2: A Key Survival-Related Gene and Restricting Antitumor Immunity in Glioblastoma.

Journal: Cancer science

Published: July 02, 2025

Dissecting the histological heterogeneity of ovarian carcinosarcoma and high-grade serous ovarian cancer in primary and metastatic tumors by single-cell transcriptomic analysis.

Dissecting the histological heterogeneity of ovarian carcinosarcoma and high-grade serous ovarian cancer in primary and metastatic tumors by single-cell transcriptomic analysis.

Journal: Chinese medical journal

Published: February 18, 2025

Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53.

Smad1 Promotes Tumorigenicity and Chemoresistance of Glioblastoma by Sequestering p300 From p53.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 02, 2024

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.

p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme.

Journal: BMC cancer

Published: August 09, 2023

Identification of DNA variants at ultra-low variant allele frequencies via Taq polymerase cleavage of wild-specific blockers.

Identification of DNA variants at ultra-low variant allele frequencies via Taq polymerase cleavage of wild-specific blockers.

Journal: Analytical and bioanalytical chemistry

Published: July 11, 2023

Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers.

Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers.

Journal: iScience

Published: February 13, 2023

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma.

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma.

Journal: Cell death discovery

Published: July 06, 2022

SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization.

SHF Acts as a Novel Tumor Suppressor in Glioblastoma Multiforme by Disrupting STAT3 Dimerization.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 09, 2022

The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity.

The positive regulatory loop of TCF4N/p65 promotes glioblastoma tumourigenesis and chemosensitivity.

Journal: Clinical and translational medicine

Published: December 19, 2021

Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.

Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.

Journal: Cancer communications (London, England)

Published: October 19, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026